COMMUNIQUÉS West-GlobeNewswire
-
Solésence Reports Second Quarter 2026 Financial Results
19/08/2026 -
Alvotech Announces Financial Results for the First Half of 2026 and Provides a Business Update
19/08/2026 -
Alvotech Announces Financial Results for the First Half of 2026 and Provides a Business Update
19/08/2026 -
Dr. Jacqueline Youtsos Expands Access to Dermatology and Medical Aesthetics with ReNu Medical & Spa in Parsons
19/08/2026 -
DNA X, Inc. Reports Second Quarter 2026 Financial Results
19/08/2026 -
Regeneron Announces Investor Conference Presentations
19/08/2026 -
Merit Medical Announces Global Operations Leadership Transition
19/08/2026 -
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
19/08/2026 -
Longeveron Appoints Nirav Jhaveri as Chief Financial Officer
19/08/2026 -
Opus Genetics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
19/08/2026 -
Edesa Biotech Announces Proposed Public Offering
19/08/2026 -
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
19/08/2026 -
FDA Authorizes First-of-Its-Kind Robotic Blood Draw Device
19/08/2026 -
Southern Sky Brands Announces Three New Vape Products in Collaboration with Martin’s in Jackson, Mississippi, Portions of Proceeds to Benefit Veterans Charity
19/08/2026 -
What Clinicians Evaluate Before Prescribing Low Dose Naltrexone Online
19/08/2026 -
Pasatru™ (garetosmab-grts) First and Only FDA-approved Treatment Demonstrating Reduction in New Heterotopic Ossification (HO) Lesions and Clinician-Assessed Flare-ups in a Placebo-controlled Trial in Adults with Fibrodysplasia Ossificans Progressiva (FOP)
19/08/2026 -
Interim Report Q2 2026: Successful reception of Evolve3 headsets and gross margin improvement boding well for strong H2 2026
19/08/2026 -
H1 2026: Novonesis delivered strong 8% organic sales growth and increases full-year outlook
19/08/2026 -
Interim report H1 2026
19/08/2026
Pages